Results 71 to 80 of about 4,675 (154)

Unique/Rapid Feedback Mechanisms of PGD2 and PGE2 as Local/Short‐Lived Autacoids; Implications of Biased Activities by Their Metabolites

open access: yesBioEssays, Volume 48, Issue 7, July 2026.
Since autacoids are short‐lived bioactive substances that act near their site of biosynthesis, the biased activities of prostanoid metabolites may have significant physiological implications with regard to the newly defined and/or re‐acknowledged as unique and novel nongenomic feedback mechanisms, which may be one of very important roles of prostanoids
Hiromichi Fujino, Keijo Fukushima
wiley   +1 more source

Clinical applications of Palmitoylethanolamide in pain management: protocol for a scoping review

open access: yes, 2019
Protocol of a scoping review focusing on applications of the Palmitoylethanolamide in the chronic pain management and its ...
Sveva Di Franco, Marco Fiore
core   +1 more source

Reprogramming lipid metabolism for cognitive restoration in Alzheimer's via PLA2G4E

open access: yesAlzheimer's &Dementia: Translational Research &Clinical Interventions, Volume 12, Issue 3, July/September 2026.
Abstract INTRODUCTION Growing evidence implicates dysregulated brain lipid metabolism in Alzheimer's disease (AD) pathogenesis, influencing membrane integrity, neuroinflammation, and amyloid beta and tau pathology, thereby representing a promising therapeutic target.
Sara Badesso   +6 more
wiley   +1 more source

Cannabidiol and cannabigerol ameliorate steatotic liver disease via phosphocreatine buffering and lysosomal restoration

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 12, Page 3173-3194, June 2026.
Cannabidiol (CBD) and cannabigerol (CBG) alleviate hepatic steatosis in obese mice by shifting energy buffering towards phosphocreatine and enhancing lysosomal lipid degradation and trafficking. These effects are associated with increased creatine kinase activity and lysobisphosphatidic acid (LBPA) levels, highlighting a previously unrecognised ...
Radka Kočvarová   +12 more
wiley   +1 more source

A Novel Function of Nonadecanoic Acid in Regulating Glucose Homeostasis

open access: yesAdvanced Science, Volume 13, Issue 26, 8 May 2026.
This study identifies the odd‐chain fatty acid C19:0 as an endogenous ligand of GPR120 that promotes glucose homeostasis via Gαq signaling. In obesity, elevated palmitic acid suppresses endogenous C19:0 production through a miRNA–PPARα–HACL1 pathway, offering a promising direction for understanding the role of OCFAs in human health.
Yanting Hou   +14 more
wiley   +1 more source

Add-on administration of ultramicronized palmitoylethanolamide in the treatment of new-onset burning mouth syndrome

open access: yes, 2019
Domenico Chirchiglia,1 Pasquale Chirchiglia,1 Rosa Marotta,2 Luca Gallelli3 1Department of Neurosurgery, University of Catanzaro, Campus Germaneto, Catanzaro 88100, Italy; 2Department of Medical-Surgical Sciences, University of Catanzaro, Campus ...
Gallelli L   +3 more
core  

Analogues and homologues of N-palmitoylethanolamide, a putative endogenous CB(2) cannabinoid, as potential ligands for the cannabinoid receptors

open access: yes, 1999
peer reviewedThe presence of CB(2) receptors was reported in the rat basophilic cell line RBL-2H3 and N-palmitoylethanolamide was proposed as an endogenous, potent agonist of this receptor. We synthesized a series of 10 N-palmitoylethanolamide homologues
Delzenne, Nathalie M.   +16 more
core   +1 more source

Polydatin Inhibits Neuroinflammation in Cerebral Ischemia–Reperfusion Injury Through Suppressing the CXCL3/CXCR2 Axis

open access: yesCNS Neuroscience &Therapeutics, Volume 32, Issue 5, May 2026.
PD can act on the CXCL3/CXCR2 axis, thereby inhibiting migration and activation of microglia and neutrophils, and thus alleviating the inflammatory response associated with CIRI, highlighting its potential as a therapeutic agent for CIRI. ABSTRACT Aim The aim of this study is to investigate the precise mechanisms by which Polydatin (PD) ameliorates ...
Youxiang Cui   +11 more
wiley   +1 more source

Palmitoylethanolamide, a neutraceutical, in nerve compression syndromes: efficacy and safety in sciatic pain and carpal tunnel syndrome

open access: yes, 2015
Jan M Keppel Hesselink, David J Kopsky Institute for Neuropathic Pain, Bosch en Duin, the NetherlandsAbstract: Palmitoylethanolamide (PEA) is an endogenous lipid modulator in animals and humans, and has been evaluated since the 1970s as an anti ...
Kopsky DJ, Keppel Hesselink JM
core  

Fixed combination of palmitoylethanolamide and melatonin in preventive therapy of migraine: results from a randomized clinical trial

open access: yesFrontiers in Nutrition
IntroductionMigraines are neurological disorders which significantly impact quality of life. Current pharmacological treatments often have adverse effects, prompting the search for alternatives with fewer side effects.
Vincenzo Piccolo   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy